---
title: "Humira (adalimumab) in rheumatoid arthritis: Access and coverage questions"
description: "Access and coverage questions on Humira (adalimumab) in rheumatoid arthritis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing. Questions: What are the Humira NDC numbers for the 40 mg RA dose? 1 question quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/access-and-coverage"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Humira (adalimumab) in rheumatoid arthritis: Access and coverage questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Humira](https://www.rxabbvie.com/pdf/humira.pdf)

Access and coverage questions that apply to every indication of Humira are on [Humira (adalimumab), all indications: Access and coverage](https://www.evicenter.com/medical-information/humira/access-and-coverage).

## Access and billing

<a id="humira-ra-ndc"></a>

### What are the Humira NDC numbers for the 40 mg RA dose?

> “RHEUMATOID ARTHRITIS
> Recommended Dose
>
> HUMIRA Prefilled Syringe
> 40 mg/0.4 mL
> NDC: 0074-0243-02
>
> 40 mg
> Every Other Week
>
> OR
>
> HUMIRA Pen
> 40 mg/0.4 mL
> NDC: 0074-0554-02
>
> 40 mg
> Every Other Week”

Source: [HUMIRA: HUMIRA® (adalimumab) Dosing Information for Healthcare professionals, captured 2026-11-13](https://www.humirapro.com/dosing#:~:text=active%20psoriatic%20arthritis.-,RHEUMATOID%20ARTHRITIS,Every%20Other%20Week)

> “• Prefilled Syringe Carton - 40 mg/0.4 mL 
> HUMIRA is supplied in a carton containing two alcohol preps and two dose trays. Each dose 
> tray consists of a single-dose, 1 mL prefilled glass syringe with a fixed thin wall, ½ inch 
> needle, providing 40 mg/0.4 mL of HUMIRA. The black needle cover is not made with 
> natural rubber latex. The NDC number is 0074-0243-02.”

Source: [HUMIRA: Prescribing information, page 55, captured 2026-11-13](https://www.rxabbvie.com/pdf/humira.pdf#page=55)

> “• HUMIRA Pen Carton - 40 mg/0.4 mL 
> HUMIRA is supplied in a carton containing two alcohol preps and two dose trays. Each dose 
> tray consists of a single-dose pen, containing a 1 mL prefilled glass syringe with a fixed thin”

Source: [HUMIRA: Prescribing information, page 54, captured 2026-11-13](https://www.rxabbvie.com/pdf/humira.pdf#page=54)

> “wall, ½ inch needle, providing 40 mg/0.4 mL of HUMIRA. The black needle cover is not 
> made with natural rubber latex. The NDC number is 0074-0554-02.”

Source: [HUMIRA: Prescribing information, page 55, captured 2026-11-13](https://www.rxabbvie.com/pdf/humira.pdf#page=55)

> “• HUMIRA Pen Carton - 40 mg/0.8 mL 
> HUMIRA is supplied in a carton containing two alcohol preps and two dose trays. Each dose 
> tray consists of a single-dose pen, containing a 1 mL prefilled glass syringe with a fixed ½ 
> inch needle, providing 40 mg/0.8 mL of HUMIRA. The needle cover may contain natural 
> rubber latex. The NDC number is 0074-4339-02.”

Source: [HUMIRA: Prescribing information, page 54, captured 2026-11-13](https://www.rxabbvie.com/pdf/humira.pdf#page=54)

> “• Prefilled Syringe Carton - 40 mg/0.8 mL 
> HUMIRA is supplied in a carton containing two alcohol preps and two dose trays. Each dose 
> tray consists of a single-dose, 1 mL prefilled glass syringe with a fixed ½ inch needle, 
> providing 40 mg/0.8 mL of HUMIRA. The needle cover may contain natural rubber latex. 
> The NDC number is 0074-3799-02.”

Source: [HUMIRA: Prescribing information, page 55, captured 2026-11-13](https://www.rxabbvie.com/pdf/humira.pdf#page=55)

Note: The rheumatoid arthritis dosing page lists the 40 mg/0.4 mL pen and syringe; the Prescribing Information also lists 40 mg/0.8 mL presentations. The third and fourth passages are one entry that continues from page 54 to page 55 of the Prescribing Information.

## Related pages
- [Medical information: Humira (adalimumab): Rheumatoid arthritis](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis)
- [Indication](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/humira--rheumatoid-arthritis/dosing-and-administration)
